Cepheid Receives FDA Clearance for Xpert® GI Panel to Support Broad Detection of Gastrointestinal Pathogens

Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...
The Business Journals

Birmingham-based BioGX developing PCR test for monkeypox

A Birmingham company is working with Cepheid to develop a PCR test for monkeypox, a virus that has spread to the U.S., though the CDC classifies the threat as low. Birmingham-based BioGX is ...
FierceBiotech

Cepheid, BioGX partner on PCR tests as monkeypox spreads

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...
360Dx

Cepheid Enters Rapid Syndromic Testing Space With FDA Clearance of GI Panel

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Pharmabiz

Cepheid forms collaboration to commercialize novel dry-formulated polymerase reagents in the life sciences market

Cepheid has entered into a collaborative agreement with Takara Bio Inc. of Shiga, Japan, under which Cepheid will package and distribute a dry-formulated version of Takara's Taq HS polymerase product ...